Staphylococcal Phage in Combination with Staphylococcus Epidermidis as a Potential Treatment for Staphylococcus

Yuzuki Shimamori1,2, Shoichi Mitsunaka1,3, Hirotaka Yamashita4

  • 1Department of Microbiology, Graduate School of Medicine, Gifu University, 1-1 Yanagido, Gifu City, Gifu 501-1194, Japan.

Viruses
|December 30, 2020
PubMed

Insights

Bacteriophage therapy using SaGU1 effectively treats atopic dermatitis by reducing Staphylococcus aureus. This approach preserves healthy skin microbiota and prevents the emergence of drug-resistant bacteria, offering a promising alternative to antibiotics.

Area of Science:

  • Microbiology
  • Dermatology
  • Bacteriophage Therapy

Background:

  • Atopic dermatitis is linked to Staphylococcus aureus overgrowth, a common skin pathogen.
  • Antibiotic use for S. aureus can disrupt the skin microbiota and lead to resistance.
  • Phage therapy presents a potential alternative for treating S. aureus-related skin conditions.

Purpose of the Study:

  • To evaluate the efficacy of Staphylococcus aureus phage SaGU1 in an atopic dermatitis mouse model.
  • To determine if SaGU1 can counteract S. aureus-induced exacerbation of atopic dermatitis.
  • To investigate the impact of co-culturing with Staphylococcus epidermidis on SaGU1 resistance.

Main Methods:

  • An atopic mouse model was used to assess SaGU1 treatment on the back skin.
  • S. aureus counts and atopic dermatitis exacerbation markers (IgE, histopathology) were measured.
  • Co-culture experiments with S. aureus and S. epidermidis were performed to study resistance development.

Main Results:

  • SaGU1 administration reduced S. aureus counts and disease severity in the mouse model.
  • S. aureus-induced atopic dermatitis exacerbation, including IgE levels and skin lesions, was ameliorated by SaGU1.
  • Staphylococcus epidermidis attenuated the emergence of SaGU1-resistant S. aureus in co-culture.

Conclusions:

  • Phage therapy with SaGU1 is a promising strategy for treating atopic dermatitis.
  • SaGU1 effectively targets S. aureus without disrupting the skin microbiota.
  • The presence of commensal bacteria like S. epidermidis may prevent phage resistance.

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
75.1K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.0K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.8K